Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaferon plus Ribavirin in Chronic Hepatitis C
NCT00527540Phase 3Completed
- Sponsor
- Tehran Hepatitis Center
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated interferon alpha in hepatitis C (HCV), sponsored by Tehran Hepatitis Center. Started Feb 2007; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00527540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527540.